These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 14565831)

  • 1. Comparisons of the skeletal locations of putative plutonium-induced osteosarcomas in humans with those in beagle dogs and with naturally occurring tumors in both species.
    Miller SC; Lloyd RD; Bruenger FW; Krahenbuhl MP; Polig E; Romanov SA
    Radiat Res; 2003 Nov; 160(5):517-23. PubMed ID: 14565831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone cancers in Mayak workers.
    Koshurnikova NA; Gilbert ES; Sokolnikov M; Khokhryakov VF; Miller S; Preston DL; Romanov SA; Shilnikova NS; Suslova KG; Vostrotin VV
    Radiat Res; 2000 Sep; 154(3):237-45. PubMed ID: 10956428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung, liver and bone cancer mortality after plutonium exposure in beagle dogs and nuclear workers.
    Wilson DA; Mohr LC; Frey GD; Lackland D; Hoel DG
    Health Phys; 2010 Jan; 98(1):42-52. PubMed ID: 19959950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal location of radiation-induced and naturally occurring osteosarcomas in man and dog.
    Thurman GB; Mays CW; Taylor GN; Keane AT; Sissons HA
    Cancer Res; 1973 Jul; 33(7):1604-7. PubMed ID: 4516008
    [No Abstract]   [Full Text] [Related]  

  • 5. Bone cancer occurrence among beagles given 239Pu as young adults.
    Lloyd RD; Taylor GN; Angus W; Bruenger FW; Miller SC
    Health Phys; 1993 Jan; 64(1):45-51. PubMed ID: 8416214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response relationships for bone cancers from plutonium in dogs and people.
    Muggenburg BA; Mewhinney JA; Griffith WC; Hahn FF; McClellan RO; Boecker BB; Scott BR
    Health Phys; 1983; 44 Suppl 1():529-35. PubMed ID: 6862927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sites of incidence of osteosarcoma in the long bones of man and the beagle.
    Spiers FW; Beddoe AH
    Health Phys; 1983; 44 Suppl 1():49-64. PubMed ID: 6575001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of age at time of exposure to 226Ra or 239Pu on distribution, retention, postinjection survival, and tumor induction in beagle dogs.
    Bruenger FW; Lloyd RD; Miller SC
    Radiat Res; 1991 Mar; 125(3):248-56. PubMed ID: 2000447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity of inhaled plutonium dioxide in beagle dogs.
    Muggenburg BA; Guilmette RA; Mewhinney JA; Gillett NA; Mauderly JL; Griffith WC; Diel JH; Scott BR; Hahn FF; Boecker BB
    Radiat Res; 1996 Mar; 145(3):361-81. PubMed ID: 8927705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of natural incidence and radiosensitivity for bone cancer in dogs.
    Taylor GN; Lloyd RD; Mays CW; Miller SC; Jee WS; Mori S; Shabestari L; Li XJ
    Health Phys; 1997 Oct; 73(4):679-83. PubMed ID: 9314230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary bone neoplasms in beagle dogs exposed by inhalation to aerosols of plutonium-238 dioxide.
    Hahn FF; Mewhinney JA; Merickel BS; Guilmette RA; Boecker BB; McClellan RO
    J Natl Cancer Inst; 1981 Oct; 67(4):917-27. PubMed ID: 6944558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of skeletal malignancies in beagles injected with 239Pu citrate.
    Lloyd RD; Taylor GN; Angus W; Miller SC; Bruenger FW; Jee WS
    Health Phys; 1994 Apr; 66(4):407-13. PubMed ID: 8138406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 238Pu: a review of the biokinetics, dosimetry, and implications for human exposures.
    Suslova KG; Khokhryakov VF; Sokolova AB; Miller SC
    Health Phys; 2012 Mar; 102(3):251-62. PubMed ID: 22420017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 238Pu: accumulation, tissue distribution, and excretion in Mayak workers after exposure to plutonium aerosols.
    Suslova KG; Sokolova AB; Khokhryakov VV; Miller SC
    Health Phys; 2012 Mar; 102(3):243-50. PubMed ID: 22420016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone tumors induced by inhalation of 238PuO2 in dogs.
    Park JF; Lund JE; Ragan HA; Hackett PL; Frazier ME
    Recent Results Cancer Res; 1976; (54):17-35. PubMed ID: 1070720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone sarcomas in 239Pu-treated mice.
    Svoboda V; Klener V; Bubeníková D; Globocnik E
    Neoplasma; 1980; 27(1):3-10. PubMed ID: 6929411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Speculated risk to bone and liver from 239 Pu.
    Mays CW; Taylor GN; Jee WS; Dougherty TF
    Health Phys; 1970 Nov; 19(5):601-10. PubMed ID: 5284408
    [No Abstract]   [Full Text] [Related]  

  • 18. Failure of interferon to inhibit plutonium-induced osteosarcomas in mice.
    Taylor GN; Kern ER; Braaten B; Glasgow LA; Wrenn ME; Atherton DA; Mays CW; Charrier K; Ayoroa G
    J Natl Cancer Inst; 1984 May; 72(5):1137-40. PubMed ID: 6201642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation risk of malignant neoplasms in organs of main deposition for plutonium in the cohort of Mayak workers with regard to histological types.
    Labutina EV; Kuznetsova IS; Hunter N; Harrison J; Koshurnikova NA
    Health Phys; 2013 Aug; 105(2):165-76. PubMed ID: 23799501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strain differences in carcinogenic and hematopoietic responses of mice after injection of plutonium citrate.
    Oghiso Y; Yamada Y
    Radiat Res; 2000 Oct; 154(4):447-54. PubMed ID: 11023609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.